Siemens Healthcare Diagnostics Gmbh

Ortho-clinical Diagnostics, Inc

Michael Avdenko

Nicolae Dumitrescu

Robert Adolfsen

Dario Svenjak

James D Shaw

Stuart Gilmour MacDonald

Merrit Nyles Jacobs

Michael W LaCourt

James Daniel Riall

Dale Robert Ryan

David Donald Hyde

Joseph John Dambra

Randy Kristopher Bower

Christopher Michael Parobek

Moses Peter

Lee William David

Jim Shaw

Merrit Jabobs

Mark Alan Simon

A random access, high-throughput system and method for preparing a biological sample for polymerase chain reaction (PCR) testing are disclosed. The system includes a nucleic acid isolation/purification apparatus and a PCR apparatus. The nucleic acid isolation/purification apparatus magnetically captures nucleic acid (NA) solids from the biological sample and then suspends the NA in elution buffer solution. The PCR testing apparatus provides multiple cycles of the denaturing, annealing, and elongating thermal cycles. More particularly, the PCR testing apparatus includes a multi-vessel thermal cycler array that has a plurality of single-vessel thermal cyclers that is each individually-thermally-controllable so that adjacent single-vessel thermal cyclers can be heated or cooled to different temperatures corresponding to the different thermal cycles of the respective PCR testing process.

Random access system and method for polymerase chain reaction testing

Methods and apparatus are adapted to wash magnetic particles isolated in a vessel. The methods include providing a vessel with wash liquid and a layer of magnetic particles, providing a probe having aspiration capability, positioning a probe tip above the layer of magnetic particles, aspirating at least some of the wash liquid above the layer, positioning the probe tip below the layer, and aspirating at least some of the wash liquid from below the layer of magnetic particles. The suction may be turned off as the probe tip descends past the layer. A novel magnetic particle washing apparatus are disclosed.

Magnetic particle washing apparatus and method

The invention is a method for detecting failures in an analyzer for conducting clinical assays. Potential errors that can result in assay failures in an analyzer are identified, as are their potential sources. The probability that an error source so identified will result in a clinically significant error is also determined. Available potential detection measures corresponding to the source of potential errors are identified with a combination of such measures selected and implemented based on their probability of detecting such errors within an acceptable limit with a concomitant low probability of the false detection of an assay failure. Each of the measures selected are functionally independent of others chosen to address the source of the error and are not subject to the same inherent means of failed detection. Applications of the method in a clinical analyzer are also presented.

Failure detection in automated clinical analyzers

A sample handler includes a plurality of sealable metering tips, each of the tips, when sealed, containing a fluid volume of a test fluid and in which each of the sealed metering tips acts as an auxiliary sample supply container for use with at least one chemistry system of a clinical analyzer.

Auxiliary sample supply for a clinical analyzer

The accurate determination of the presence of a fluid in a container is determined by assessing the difference in various pressure readings relative to a threshold value. The method distinguishes between actual aspiration of a fluid and aspiration of a film that can otherwise lead one to believe that fluid has been aspirated when it has not. The method is particularly useful in clinical analyzers such as automated enzyme immunoassay devices.

Thin film detection during fluid aspiration

Growing community of inventors

Rochester, NY, United States of America

Michael Avdenko